StellarQ My self-reporting Spinal Muscular Atrophy (SMA) and Duchenne Muscular Dystrophy (DMD)

A mobile application for self-reporting spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD). Using the app helps the healthcare professionals responsible for your treatment to understand your overall situation.

By authenticating with your online banking credentials, you can access the self-reporting feature for SMA and DND if you have an active treatment relationship with the well-being area unit where the StellarQ service is available, and if your treatment plan includes self-reporting.

Benefits of self-reporting

You help healthcare professionals responsible for your treatment understand your situation before the start of treatment.
You enable healthcare professionals to monitor your situation in real-time and assess the effectiveness of your treatment.
You assist healthcare professionals responsible for your treatment in achieving the best treatment outcome.

Purposes of Using Generated Material

The service manages personal and health information recorded by the patient and transmits this health information to the unit responsible for the patient's care. Information that cannot identify an individual patient may be used for research purposes, development of treatments, and compilation of comparative data.

Security

The service is accessed with a strong identifier through the suomi.fi authentication service designed for official transactions. Only you and healthcare professionals responsible for your treatment can access your information. The data is stored on a server that complies with the official requirements for sensitive information.

Developed in collaboration with experts and users

StellarQ My service is developed in collaboration with healthcare professionals and users.